Event: NJ AIChE September Meeting

NJAIChE September Meeting
The NJ AIChE Chapter is hosting a dinner at Rutgers University, with guest speaker Dr. Futran. Dinner is free for students.

When: September 11th, 2012 - Tuesday - 6:00pm (sign in)
Where: Busch Campus Dining Room A
To RSVP: email rsvp@njaiche.org confirming your attendance and CC rutgers.aiche@gmail.com

You must RSVP by September 7th, 2012

Dress code: business casual

Additional information: http://www.njaiche.org/2012/08/22/njaiche-september-meeting-2/


Pharmaceutical processes include, among others, chemical synthesis, formulation of solid oral dosage forms, and manufacture of biological molecules via cell culture, fermentation or synthesis. Synthetic processes for small molecules have common elements with the fine chemicals industry.  Processes for solid dose oral formulations revolve around the science and technology of organic solids processing, which has commonality with other industries such as catalyst manufacture, munitions, food, detergents, etc.  The processes for biomolecules share many elements with biofuels and biofeedstocks.  However, the regulatory framework for pharmaceuticals is much more complex than other industries, and as a result the state of the art is different than in other industries.

This talk addresses opportunities to enhance the development of these pharmaceutical processes and the impact of properly engineered development on the resulting manufacturing processes.  This is crucial for the industry in this age of distributed supply chains and outsourcing, which is also present in other industries.  Ensuring the supply and quality of pharmaceutical products requires a renewed emphasis on acquiring fundamental understanding during development so that the process can be controlled effectively in this array of suppliers.  Furthermore the time and cost of development must be reduced.  The thousands of manufacturers involved in pharmaceuticals around the globe cannot reach this level of engineering on their own.  The talk presents examples of current and potential academic contributions, such as dynamic analysis for process control, the science of particulate systems and the development of continuous manufacturing for solid oral dosage forms, and perspectives for the use of continuous approaches in developing biomanufactured products.